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Aortic valves are antigenic but less so than 
myocardium 
To the Editor: 
We read with interest wo articles, one by Rajani, Mee, 
and Ratliff I and the other by Mitchell, Jonas, and 
Schoen, 2and noted especially the difference in the results 
regarding immunologic reactions of the aortic valves. In 
our primate heterotopic heart allotransplant model, do- 
nor aortic valves were rejected more weakly than myocar- 
dium. Mononuclear cells infiltrated into 90% of the donor 
aortic valves? 
Ten adult male macaque monkeys were subjected to 
heterotopie cardiac allotransplantation without immuno- 
suppressive drugs. Allotransplanted hearts were rejected 
and stopped beating after 8 to 27 days. Pathologic exam- 
ination revealed grade 3 to 4 rejection of the myocardial 
tissues in all the grafts. Aortic valves from six donor hearts 
showed subendothelial cell infiltration, and in three donor 
hearts there was cell infiltration into the stroma (Fig. 1), 
but valves from one donor showed normal structure 
without inflammatory cells. All animals received humane 
animal care in compliance with "Standards Relating to the 
Care and Management, Etc. of Experimental Animals 
(Notification No. 6, March 27, 1980, of the Prime Minis- 
ter's Office, Japan)." 
The antigenicity of the valves is so weak that the valves 
from the immunosuppressed recipient in Mitchell's stud- 
ies did not show immunologic findings such as cell infil- 
tration. In rodents, donor-specific cellular and humoral 
immune responses after aortic valve allografting were 
reported as similar in magnitude to skin allografting but 
somewhat slow in onset. Cyclosporine (INN: ciclosporin) 
arrested the homograft degeneration. 4'5 The results of 
these studies including ours suggest hat small-dose im- 
munosuppression may arrest homograft degeneration, 
especially in infants, as in Rajani's report. 
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Fig. 1. Aortic valve with cell infiltration into the stroma. 
Mononuclear ceils infiltrated into the stroma and normal 
valve structures are destroyed. The aortic valve was re- 
trieved from the donor heart with grade 4 rejection. 
(Hematoxylin-eosin taining, original magnification x80). 
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The pathologic findings in aortic valves by Kawauchi 
and associates I in heterotopic heart allotransplant pri- 
mates are very interesting. They report mononuclear cell 
infiltration in 90% of donor aortic valves examined 8 to 27 
days after transplantation. These findings are similar to 
the observations in our study, 2 in which failed homograft 
(allograft) cardiac valves removed from infants demon~- 
strated lymphocytic infiltration n valve leaflets and aortic 
sleeves. 2 In contrast, Mitchell and coauthors, 3 who exam- 
ined explanted cryopreserved homograft heart valves and 
valves removed from transplanted homograft hearts, 
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found infiltration of valves by inflammatory cells to be 
absent or minimal. Although in Mitchell's study ho- 
mograft valves were examined at many postoperative 
intervals, valves that were removed 9 days to 2 months 
after implantation were not studied because the speci- 
mens were unavailable. Furthermore, the valves that were 
cxplanted at 2 to 4 months (n = 3) did demonstrate a 
prominent inflammatory infiltrate, including neutrophils, 
macrophages, and T-lymphocytes. However, these valves 
had failed because of infective endocarditis; therefore, 
even if there was a component of the infiltrate that may 
have been related to a rejection process, this would have 
been impossible to prove. In Mitchell's tudy, if the valves 
that failed because of infective endocarditis are dis- 
counted, the potential temporal window during which it is 
possible that immunologically mediated injury could have 
occurred undetected would be between 9 days and 6 
months. It is interesting that the valves in Kawauchi's 
study were examined 8 to 27 days after transplantation. 
This period almost fits into the aforementioned window of 
time. In our study, 2 mononuclear cell infiltrates were 
found in five infant cryopreserved homograft valves ex- 
planted after 6.5 to 31 weeks. It may be that this interme- 
diate implant interval represents he peak time for cellular 
rejection of homograft valves, especially in the younger 
pediatric population. 
We recently studied in detail nine homograft valves that 
were explanted from two children and seven adults whose 
ages ranged from 4 to 61 years. The time from valve 
insertion to removal in these patients ranged from 8 
months to 23 years. In contrast to the homograft valves in 
infants, infiltration by mononuclear cells was not ob- 
served. We noted moderate to marked intimal hyperplasia 
(composed of spindle cells positive for smooth muscle 
actin) in seven of the nine non-infant homografts. The 
intimal proliferation was very similar to the intima in graft 
vascular disease in solid organ transplants. Assuming that 
graft vascular disease is a form of rejection, the hyperplas- 
tic intima in these allografts would then represent ongoing 
rejection. We continue to believe that allograft valves in 
any age group arc not immunologically privileged. 
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Reply to the Editor." 
We read with interest he letter written by Kawauchi 
and associates 1 in response to our article concerning the 
pathology of explanted cryopreserved allograft heart 
valves versus aortic valves from orthotopic heart trans- 
plants. 2In a primate heterotopic heart transplant model, 
Kawauchi and colleagues have observed mononuclear 
inflammatory cells in association with the allograft aortic 
valve and have interpreted this to represent cell-mediated 
"rejection." Since they observe that the extent of inflam- 
matory infiltrate in the valves is lower than that seen 
within the myocardium proper, the authors also infer that 
the rejection of valves is weaker than that of the myocar- 
dium. As in the recent paper by Rajani and colleagues, 3 
the criteria that permit he presence of mononuclear cell 
infiltrates in valves to be interpreted as immunologically 
specific rejection are not stated. Moreover, there is no 
evidence that valve degeneration or dysfunction can be 
attributed to the inflammatory cells. Nevertheless, on the 
basis of these findings, as well as those reported previously 
in rat allograft valve experiments, < 5Kawauchi and asso- 
ciates 1suggest that "small-dose immunosuppression may 
arrest homograft degeneration." 
We believe that it is extremely important to respond to 
the lcttcr and to clearly reiterate two points that we made 
in our original article: (1) Tissue immunogenicity s not 
equivalent to immunologically mediated ysfunction. (2) 
Although inflammatory cell infiltrates are characteristi- 
cally associated with rejection, the presence of such cells 
does not necessarily denote a rejection pathogenesis. 
As regards the first point, allograft valves clearly may 
induce a detectable humoral and/or cellular allogencic 
response. 4-8 Indeed, it would be unusual if tissue express- 
ing foreign histocompatibility antigens did not elicit a 
detectable r sponse. However, there is not evidence that 
the observed loss of cellularity and architectural degener- 
ation of cryopreserved allograft valves can be attributed to 
such immunologic responses. Indeed, some sort of immu- 
nologic variant of Koch's postulates* should be satisfied 
before one concludes that immune destruction is the basis 
for valve failure. Essentially, it is first necessary to dem- 
onstrate that immunologically specific elements (antibod- 
ies or cells) are associated with failing valves; by the 
judicious use of isografts, an important corollary is that 
antibodies and cells found on valves are not nonspecifi- 
cally present because of surgical manipulation oraberrant 
flow conditions. The second step would be to use antibod- 
ies or cells from animals that have dysfunctional trans- 
planted valves and cause valve degeneration by transfer 
*To firmly establish that a specific bacterium isresponsible for a 
specific human disease, Robert Koch in the late nineteenth 
century proposed a set of objective criteria. These Koch's 
Postulates tate that the suspected bacterium should be 
routinely recovered from the pathologic lesions of the human 
host; in a pure form, these bacteria should cause the patho- 
logic lesions when inoculated into an animal host; and, tile 
bacterium should then be recoverable from the pathologic 
lesions in the animal. 
